A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors

Although more and more evidence supports CDC28 protein kinase subunit 1B (CKS1B) is involved significantly in the development of human cancers, most of the researches have focused on a single disease, and pan-cancer studies conducted from a holistic perspective of different tumor sources have not be...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yan Jia, Quan Tian, Kaitai Yang, Yi Liu, Yanfeng Liu
Formato: article
Lenguaje:EN
Publicado: Hindawi Limited 2021
Materias:
R
Acceso en línea:https://doaj.org/article/db1d50ff15464faf850ae9a02d2d5992
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:db1d50ff15464faf850ae9a02d2d5992
record_format dspace
spelling oai:doaj.org-article:db1d50ff15464faf850ae9a02d2d59922021-11-29T00:55:43ZA Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors2314-614110.1155/2021/5862941https://doaj.org/article/db1d50ff15464faf850ae9a02d2d59922021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/5862941https://doaj.org/toc/2314-6141Although more and more evidence supports CDC28 protein kinase subunit 1B (CKS1B) is involved significantly in the development of human cancers, most of the researches have focused on a single disease, and pan-cancer studies conducted from a holistic perspective of different tumor sources have not been reported yet. Here, for the first time, we investigated the potential oncogenic and prognostic role of CKS1B across 33 tumors based on public databases and further verified it in a small scale by RNA sequencing or quantitative real-time PCR. CKS1B was generally highly expressed in a majority of tumors and had a notable correlation with the prognosis of patients, but its prognostic significance in different tumors was not exactly the same. In addition, CKS1B expression was also closely related to the infiltration of cancer-associated fibroblasts in tumors such as breast invasive carcinoma, kidney chromophobe, lung adenocarcinoma, and tumor-infiltrating lymphocytes in tumors such as glioblastoma multiforme, bladder urothelial carcinoma, and brain lower grade glioma. Moreover, reduced CKS1B methylation was observed in certain tumors, for example, adrenocortical carcinoma. Cell cycle and kinase activity regulation and PI3K-Akt signaling pathway were found to be involved in the functional mechanism of CKS1B. In conclusion, our first pan-cancer analysis of CKS1B contributes to a better overall understanding of CKS1B and may provide a new target for future cancer therapy.Yan JiaQuan TianKaitai YangYi LiuYanfeng LiuHindawi LimitedarticleMedicineRENBioMed Research International, Vol 2021 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
spellingShingle Medicine
R
Yan Jia
Quan Tian
Kaitai Yang
Yi Liu
Yanfeng Liu
A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors
description Although more and more evidence supports CDC28 protein kinase subunit 1B (CKS1B) is involved significantly in the development of human cancers, most of the researches have focused on a single disease, and pan-cancer studies conducted from a holistic perspective of different tumor sources have not been reported yet. Here, for the first time, we investigated the potential oncogenic and prognostic role of CKS1B across 33 tumors based on public databases and further verified it in a small scale by RNA sequencing or quantitative real-time PCR. CKS1B was generally highly expressed in a majority of tumors and had a notable correlation with the prognosis of patients, but its prognostic significance in different tumors was not exactly the same. In addition, CKS1B expression was also closely related to the infiltration of cancer-associated fibroblasts in tumors such as breast invasive carcinoma, kidney chromophobe, lung adenocarcinoma, and tumor-infiltrating lymphocytes in tumors such as glioblastoma multiforme, bladder urothelial carcinoma, and brain lower grade glioma. Moreover, reduced CKS1B methylation was observed in certain tumors, for example, adrenocortical carcinoma. Cell cycle and kinase activity regulation and PI3K-Akt signaling pathway were found to be involved in the functional mechanism of CKS1B. In conclusion, our first pan-cancer analysis of CKS1B contributes to a better overall understanding of CKS1B and may provide a new target for future cancer therapy.
format article
author Yan Jia
Quan Tian
Kaitai Yang
Yi Liu
Yanfeng Liu
author_facet Yan Jia
Quan Tian
Kaitai Yang
Yi Liu
Yanfeng Liu
author_sort Yan Jia
title A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors
title_short A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors
title_full A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors
title_fullStr A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors
title_full_unstemmed A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors
title_sort pan-cancer analysis of clinical prognosis and immune infiltration of cks1b in human tumors
publisher Hindawi Limited
publishDate 2021
url https://doaj.org/article/db1d50ff15464faf850ae9a02d2d5992
work_keys_str_mv AT yanjia apancanceranalysisofclinicalprognosisandimmuneinfiltrationofcks1binhumantumors
AT quantian apancanceranalysisofclinicalprognosisandimmuneinfiltrationofcks1binhumantumors
AT kaitaiyang apancanceranalysisofclinicalprognosisandimmuneinfiltrationofcks1binhumantumors
AT yiliu apancanceranalysisofclinicalprognosisandimmuneinfiltrationofcks1binhumantumors
AT yanfengliu apancanceranalysisofclinicalprognosisandimmuneinfiltrationofcks1binhumantumors
AT yanjia pancanceranalysisofclinicalprognosisandimmuneinfiltrationofcks1binhumantumors
AT quantian pancanceranalysisofclinicalprognosisandimmuneinfiltrationofcks1binhumantumors
AT kaitaiyang pancanceranalysisofclinicalprognosisandimmuneinfiltrationofcks1binhumantumors
AT yiliu pancanceranalysisofclinicalprognosisandimmuneinfiltrationofcks1binhumantumors
AT yanfengliu pancanceranalysisofclinicalprognosisandimmuneinfiltrationofcks1binhumantumors
_version_ 1718407802252165120